Renovaro investors sued in US for insider trading

A number of wealthy figures behind Danish-American Renovaro Biosciences, formerly Enochian Biosciences, have been accused of insider trading worth more than USD 4.3m.
Chairman of Renovaro Biosciences René Sindlev is one of the people that has been accused of insider trading. | Photo: David Leth Williams/STF/Ritzau Scanpix
Chairman of Renovaro Biosciences René Sindlev is one of the people that has been accused of insider trading. | Photo: David Leth Williams/STF/Ritzau Scanpix

Pandora billionaire René Sindlev and millionaire Ole Abildgaard have allegedly made millions of dollars from insider trading in the Danish-American biotech company Renovaro Biosciences, according to California court documents obtained by MedWatch.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading

Ursula von der Leyen exchanged several text messages with the CEO of Pfizer during the vaccine procurement process. | Foto: Ida Marie Odgaard

Review of EU Pfizer deal postponed

For subscribers